PF-07321332
Produktgrößen
2 mg
£168,00
F1000-2MG
10 mg
£308,00
F1000-10MG
50 mg
£542,00
F1000-50MG
100 mg
£775,00
F1000-100MG
Über dieses Produkt
- SKU:
- F1000
- Buffer:
- Powder; no buffer
- Weitere Details:
- PF-07321332 is an orally active covalent inhibitor of the 3C-like protease by direct binding of the catalytic cysteine 145. 3CL protease cleaves polyproteins 1a and 1ab of SARS-CoV-2, a step required for reproduce the virus. The PF-07321332/ritonavir combination drug (trade name Paxlovid) is efficient for the treatment of COVID-19 as, in November 2021, Pfizer announced phase 2/3 clinal trial results that the drug treatment reduced 89% in hospitalizations when given within three days after symptom onset. This product is for research use only.
- Molekulargewicht:
- 499.53 g/mol
- Versandbedingungen:
- Ambient
- Quelle:
- chemical synthesis
- Lagerbedingungen:
- -20 0C
- Hersteller:
- UBP Bio
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules
